Trivascular Obtains $40,000,000 Series E Funding Round

  • Feed Type
  • Date
    11/18/2013
  • Company Name
    Trivascular
  • Mailing Address
    3910 Brickway Blvd Santa Rosa, CA 95403
  • Company Description
    Trivascular is developing novel endovascular repair devices to treat abdominal aortic aneurysms (AAA).
  • Website
    http://www.trivascular2.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $40,000,000
  • Transaction Round
    Series E
  • Proceeds Purposes
    Proceeds from the financing will be used to expand commercial efforts worldwide and to fuel product pipeline and clinical research activities.
  • M&A Terms
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    Delphi Ventures
  • Venture Investor
    MPM Capital
  • Venture Investor
    Kearny Venture Partners
  • Venture Investor
    Kaiser Permanente Ventures
  • Venture Investor
    Redmile Group
  • Venture Investor
    Deerfield Capital
  • Venture Investor
    Permal Capital

By posting a comment, you agree to our terms and conditions.